Atlas Trials

Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation

Clinical trial NCT00579592 · TERMINATED

Trial details

NCT number
NCT00579592
Sponsor
University of Wisconsin, Madison
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute RejectionRenal Transplantation
Start date
2006-04-01
Primary completion
2007-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.